“C” to Believe: Jefferson Scientists Studying the Effects of High Dose Vitamin C on Non-Hodgkin Lymphoma Patients
(Published 1-2-2008) Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received
approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers
from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes
of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.
(Published 1-10-2008) Most likely you’ve never heard of the term “skier’s thumb” -- unless you’re one of the unlucky snow
bunnies, weekend warriors or highly trained athletes to have experienced its severe symptoms ‘first hand.’ But orthopaedic
specialists at Thomas Jefferson University Hospital say it's important to be aware of this acute injury before hitting the
slopes so you don't end up with chronic pain and dysfunction.
Jefferson Scientists Find Protein Helps Pancreatic Cancer Cells Hide from Immune System, Allowing Spread(Published 1-10-2008) A protein that helps prevent a woman’s body from rejecting a fetus may also play an important role in
enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body.
Jefferson’s Rural Physicians Program Expands into Delaware(Published 1-11-2008) The Department of Family and Community Medicine of Jefferson Medical College, Thomas Jefferson University
has received a three-year grant from the Bureau of Health Professions (Health Resources and Services Administration, US Department
of Health and Human Services) to expand its medical school educational programs. One of the five components of this expansion
is to extend Jefferson’s rural Physician Shortage Area Program (PSAP) to the state of Delaware.
